Cabot Marijuana Investor Update
The stocks in are our portfolio are gradually looking healthier, as bargain hunters invest more carefully, focusing on the stocks with the best prospects for real revenue growth and real earnings.
Read More
vape pen lung disease
Read More
vape pen lung disease Archives
Cabot Marijuana Investor Update
The broad market remains strong, while the cannabis sector remains stuck in the mud—in general.
Read More
Cabot Marijuana Investor Update
Marijuana stocks remain under pressure, as year-end tax selling pressures continue, but the marijuana industry is booming, as evidenced not only by recent quarterly reports but also by the growth of MJBizCon, the industry’s leading conference.
Read More
Cabot Marijuana Investor Update
One of our stocks is down sharply today on big volume following a report by short-sellers Grizzly Reports that accuses the company and insiders of numerous improprieties, ranging from political cronyism and corruption to overvaluation of assets to misrepresentation of financial relationships.
Read More
Cabot Marijuana Investor Update
The good news is that 2019, which started off so well for the cannabis sector but is ending so poorly, is nearing the finish line. The bad news is that we still have three weeks to go, technically, though many of those days see...
Read More
Cabot Marijuana Investor Update
Not a lot has changed since last week’s issue—overall, the cannabis sector remains in a correction—but there are a few stocks worthy of an update.
Read More
Cabot Marijuana Investor Update
Yesterday, the House Judiciary Committee approved the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act), which has Democratic Presidential candidate and former prosecutor Kamala Harris as one of its sponsors.
Read More
Cabot Marijuana Investor Update
I’m making four changes to the portfolio today.
Read More
Cabot Marijuana Investor Update
It’s been a tough few months for cannabis investors, but no downtrend lasts forever, and yesterday’s blast-off by Aphria (APHA), which sparked buying across the sector, is a sign that the worst has almost certainly passed.
Read More
Cabot Marijuana Investor Update
Yesterday was the worst day of the year for cannabis stocks, with HEXO (no longer in our portfolio) leading the way down with a plunge of 22.5% after the company announced that revenue for the fiscal fourth quarter, ended July, would be $14.5 $16.5...
Read More
Cabot Marijuana Investor Update
The cannabis sector has been trending down since the end of March, giving back its spectacular gains from the start of the year, and until now I’ve remained optimistic about our stocks, partially because of their outstanding fundamental growth metrics but also because two...
Read More
Cabot Marijuana Investor Update
In the broad market, all is well, as all trend-following indicators are positive, and the number of stocks hitting new lows has been minuscule in recent days.
Read More
The Truth About Vape Pen Lung Disease
Major media outlets are trying to scare you about vape pen lung disease. Here's the real truth about it - and what's next for marijuana stocks.
Read More
Cabot Marijuana Investor Update
One major factor in investing, particularly in small stocks and young sectors where growing pains are still the norm, is sentiment. Good sentiment can take a sector to extreme highs—as it has done for the marijuana sector at every major legalization milepost.
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up